Stability and compatibility of a mixture of the anti-cancer drugs etoposide, cytarabine and daunorubicine for infusion.
We evaluated (i) the stability of a mixture of the three anti-cancer agents used for the treatment of leukemia, namely etoposide, cytarabine and daunorubicine, in 5% glucose, and (ii) its compatibility towards various materials during an infusion protocol as performed for therapeutic purposes in hospital practice. Etoposide and cytarabine were assayed by high-performance liquid chromatography with a C18 type column and UV detection. Daunorubicine was assayed by visible spectrophotometry. The stability study showed all three anti-cancer drugs to be stable in 5% glucose solution, both alone and mixed. Best conservation was obtained by keeping bottles containing the mixture in the dark at room temperature. During the infusion protocol used in clinical practice, etoposide, cytarabine and daunorubicine were stable and compatible with the various materials present in the infusion sets and extension tubing (polyvinyl chloride, polyethylene) and catheters (silicone). Observed variations in concentration did not exceed 10% of initial concentrations of each drug, though we would advocate changing infusion sets and extension tubing daily.
Chevrier
R
R
Laboratoire de Pharmacie Clinique et Biotechnique, UFR Pharmacie, Clermont-Ferrand, France.
Sautou
V
V
Pinon
V
V
Demeocq
F
F
Chopineau
J
J
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000737:chemistry*; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D004344:Drug Incompatibility; D004355:Drug Stability; D005047:Etoposide / Q000008:administration & dosage; D007262:Infusions, Intravenous
D003561:Cytarabine; D005047:Etoposide; D003630:Daunorubicin